Dr. Jonathan Keats discusses how multiple myeloma can be multiple cancers from a genetic standpoint. Through his work with the Multiple Myeloma Research Foundation's CoMMpass Study, Dr. Keats' team has sequenced 1,150 patients from 90 sites worldwide. What does this mean for patients?